SEC Filing Summary: ChromaDex Corporation (CDXC)
Business Context and Reporting Period
This Form 8-K was filed by ChromaDex Corporation on May 29, 2020. The filing serves as a Regulation FD disclosure to distribute a corporate investor presentation made available on the company's website. The registrant is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol CDXC.
Financial Metrics
The filing text does not provide specific financial data. This document is a procedural filing to announce the release of an external presentation (Exhibit 99.1) and does not contain revenue, profit, cash flow, margin, debt, or liquidity figures within the body of the report.
Material Changes
No material changes to financial performance or operations are detailed in this specific filing text. The only reported event is the public release of the corporate presentation.
Guidance, Outlook, and Risks
Management commentary, guidance, and risk factors are contained within the attached Investor Presentation (Exhibit 99.1), which is referenced but not included in the text of this filing. The filing explicitly states that the information in the exhibit is furnished and not "filed" for purposes of Section 18 of the Exchange Act, limiting its legal liability and incorporation by reference.
Key Facts for Investor Verification
- Verify the contents of the attached Exhibit 99.1 (Investor Presentation) for actual financial guidance and operational updates.
- Confirm that the presentation is available on the company's official website as stated in Item 7.01.
- Note that the filing is signed by Kevin M. Farr, Chief Financial Officer, on May 29, 2020.
- Be aware that the information in the exhibit is not deemed "filed" under Section 18 of the Exchange Act.